Early Screening Equals Early Diagnosis

2019-06-18T16:14:25+00:00June 18th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible screening can take place in a community setting. Figure B: Percentage of each stage and type of lung cancer diagnosed at nonacademic centers compared with academic centers. Published in [...]

Lung Cancer News from the Largest Oncology Meeting

2019-06-13T16:36:27+00:00June 13th, 2019|Hot Topics, News|

The GO2 Science and Research team just returned from the 2019 American Society of Clinical Oncology (ASCO) meeting. We connect you and your loved ones to the latest research and treatment options by keeping up with the latest advances at meetings like ASCO. While there we saw exciting presentations on new research advances and potential new treatment options for lung cancer patients. Below are some key takeaways: Targeted Therapy Key Takeaway: All patients should receive comprehensive molecular testing/biomarker testing because [...]

Join Our $20 Million By 2020 Campaign to Restore Full Funding for Lung Cancer Research!

2019-05-10T13:51:07+00:00May 9th, 2019|Hot Topics|

TAKE ACTION! Through consistent advocacy efforts, GO2­ Foundation (formerly Lung Cancer Alliance) established the Lung Cancer Research Program (LCRP) within the Congressionally Directed Medical Research Programs, administered by the Department of Defense with federal appropriations of $20 million in Fiscal Year (FY) 2009. LCRP has been underfunded the past 10 years, below its original $20 million dollars level. Congress must restore the funding level back to $20 million this year. Since FY09 and through FY18, the program has been funded [...]

Research Wins Big

2019-05-17T16:57:20+00:00May 7th, 2019|Hot Topics, News|

The GO2 Foundation for Lung Cancer is honored to announce that on May 2 two of our programs received Your Cancer’s Cancer Community (C2) Awards. These awards celebrate “the unsung heroes of cancer care”—individuals and organizations that advance cancer care and work to improve the lives of those living with the disease. The Centers of Excellence (COE) program received Your Cancer’s C2 Catalyst for Care Award. This category recognized nominees making the experience of cancer care easier for patients. We [...]

New Resources for Healthcare Professionals Now Available!

2019-05-01T23:47:29+00:00May 1st, 2019|Hot Topics|

We had so many informative presentations at our 2018 Screening and Care Conference that we wanted to make sure everyone has access to this information. Check out top presentations on molecular testing and targeted therapy, improving access to care, the importance of a multidisciplinary conference for screening, and patient tracking software. They’re all on our new YouTube playlist: For Professionals.

Lung Cancer Registry Allows Patients to Help Fight Lung Cancer

2019-04-22T20:39:29+00:00April 22nd, 2019|Hot Topics|

Each year, more than 1.8 million people receive a lung cancer diagnosis. Though research and treatment options have come a long way, there is still far more work to be done to stop the number one cancer killer. The Lung Cancer Registry was created for anyone who has been diagnosed with lung cancer to allow patients to be a part of the solution. The registry is a knowledge base for lung cancer researchers working to find medical treatments through data shared [...]

We Will Get It Done Together.

2019-04-16T18:54:14+00:00April 16th, 2019|Hot Topics|

Dear Friends, It has been one week since we announced our merger forming the GO2 Foundation for Lung Cancer and shared how this new powerhouse will transform the future of lung cancer. We continue to be overwhelmed by the outpouring of support and enthusiasm and want to personally express our gratitude. Thank you to all the patients, survivors, caregivers, advocates, researchers, industry and public health leaders, who took the time to reinforce that we made a great decision that will [...]

FDA Approves First-Line Treatment for NSCLC with PD-L1 Biomarker

2019-04-12T17:39:26+00:00April 12th, 2019|Hot Topics, News|

On April 11, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA) as a first-line treatment for patients with advanced NSCLC who have a score of 1% or higher on the PD-L1 biomarker test. The approval was based on KEYNOTE-042 trial which demonstrated statistically significant OS improvements for those randomized to pembrolizumab compared with chemotherapy. Click here to read the full press release.

Priority Focus Renewed on Women’s Health Imperative – House and Senate Leaders Reintroduce Women and Lung Cancer Research and Preventive Services Act of 2019

2019-04-10T19:48:13+00:00April 10th, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer hails bipartisan effort to accelerate progress to increase survivorship April 10, 2019 - Today the GO2 Foundation for Lung Cancer praises Senators Marco Rubio (R-FL), Dianne Feinstein (D-CA), Shelley Moore Capito (R-WV), and Joe Manchin (D-WV), and Representatives Brendan Boyle (D-PA), Brian Fitzpatrick (R-PA), Debbie Dingell (D-MI), and Suzanne Bonamici (D-OR) for elevating national attention to a women’s public health imperative by re-introducing the 2018 Senate and House bills (S. 2358 and H.R. 4897) as the Women [...]